Angiogenetic potential of Ad2/Hif-1α/Vp16 after regional application in a preclinical pig model of chronic ischemia

Current Vascular Pharmacology

Volumn 11, Issue 1, 2013, Pages 29-37

  Hinkel, Rabea ^a   Lebherz, Corinna ^a   Fydanaki, Maria ^a   Wuchrer, Alexander ^a   El Aouni, Chiraz ^a   Thormann, Michael ^a   Thein, Eckart ^a   Kupatt, Christian ^a   Boekstegers, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adenovirus; Angiogenesis; Arteriogenesis; Chronic ischemia; Hif 1 alpha; Retroinfusion

Indexed keywords

ADENOVIRUS VECTOR; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MESSENGER RNA; PROTEIN VP16;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; BODY WEIGHT; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; FLUOROSCOPY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART RATE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; ISCHEMIA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); SWINE; WESTERN BLOTTING;

EID: 84873108883     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016113804547601     Document Type: Article

References (40)

1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: e21-181.
2. Atwood JE, Myers J, Colombo A, et al. The effect of complete and incomplete revascularization on exercise variables in patients undergoing coronary angioplasty. Clin Cardiol 1990; 13: 89-93.
3. Bourassa MG, Holubkov R, Yeh W, Detre KM. Strategy of complete revascularization in patients with multivessel coronary artery disease (a report from the 1985-1986 NHLBI PTCA Registry). Am J Cardiol 1992; 70: 174-8.
4. Maulik N, Thirunavukkarasu M. Growth factors and cell therapy in myocardial regeneration. J Mol Cell Cardiol 2008; 44: 219-27.
5. Levonen AL, Vahakangas E, Koponen JK, Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease-Current status and future perspectives. Circulation 2008; 117: 2142-50.
6. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003; 23: 1143-51.
7. Deindl E, Buschmann I, Hoefer I E, et al. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 2001; 89: 779-86.
8. Deindl E, Schaper W. The art of arteriogenesis. Cell Biochem Biophys 2005; 43: 1-15.
9. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003; 9: 685-93.
10. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 2005; 115: 1542-51.
11. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxiainducible factor 1. Crit Rev Oncol Hematol 2006; 59: 15-26.
12. Kupatt C, Hinkel R, Pfosser A, et al. Cotransfection of vascular endothelial growth factor-a and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion: role of vessel maturation. J Am Coll Cardiol 2010; 56: 414-22.
13. Zhang SX, Wang JX, Miller JJ, Mwasaru EF, Gozal D, Wang Y. Whole-body hypoxic preconditioning (WBHPC) protects mice against acute hypoxia by improving lung function. J Appl Physiol 2004; 96: 392-7.
14. Schultz K, Fanburg BL, Beasley D. Hypoxia and hypoxia-inducible factor-1 alpha promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006; 290: H2528-34.
15. Chowdhury R, Hardy A, Schofield CJ. The human oxygen sensing machinery and its manipulation. Chem Soc Rev 2008; 37: 1308-19.
16. Gruchala M, Roy H, Bhardwaj S, Yla-Herttuala S. Gene therapy for cardiovascular diseases. Curr Pharm Des 2004; 10: 407-23.
17. Rutanen J, Rissanen TT, Markkanen JE, et al. Adenoviral cathetermediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004; 109: 1029-35.
18. Boekstegers P, von Degenfeld G, Giehrl W, et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 2000; 7: 332-40.
19. Raake P, von DG, Hinkel R, et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004; 1124-9.
20. Raake PW, Hinkel R, Muller S, et al. Cardio-specific long-term gene expression in a porcine model after selective pressureregulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 2008; 15: 12-17.
21. Boekstegers P, Kupatt C. Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol 2004; 99: 373-81.
22. Vincent KA, Shyu KG, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor. Circulation 2000; 102: 2255-61.
23. von DG, Raake P, Kupatt C, et al. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol 2003; 42:1120-8.
24. Boekstegers P, Giehrl W, von DG, Steinbeck G. Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1998; 31: 1525-33.
25. Boekstegers P, Peter W, von DG, et al. Preservation of regional myocardial function and myocardial oxygen tension during acute ischemia in pigs: comparison of selective synchronized suction and retroinfusion of coronary veins to synchronized coronary venous retroperfusion. J Am Coll Cardiol 1994; 23: 459-69.
26. Thein E, Raab S, Harris AG, Messmer K. Automation of the use of fluorescent microspheres for the determination of blood flow. Comput Methods Programs Biomed 2000; 61: 11-21.
27. Firth JD, Ebert BL, Ratcliffe PJ. Hypoxic regulation of lactatedehydrogenase-a-interaction between hypoxia-inducible factor-1 and camp response elements. J Biol Chem 1995; 270: 21021-7.
28. Rissanen TT, Yla-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 2007; 15: 1233-47.
29. Kupatt C, Hinkel R, von Bruhl ML, et al. Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium. J Am Coll Cardiol 2007; 49: 1575-84.
30. Gray SJ, Samulski RJ. Optimizing gene delivery vectors for the treatment of heart disease. Expert Opin Biol Ther 2008; 8: 911-22.
31. Nagao K, Taniyama Y, Kietzmann T, Doi T, Komuro I, Morishita R. HIF-1 alpha signaling upstream of NKX2.5 is required for cardiac development in xenopus. J Biol Chem 2008; 283: 11841-9.
32. Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403-7.
33. Huang Y, Hickey RP, Yeh JL, et al. Cardiac myocyte-specific HIF-1 alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 2004; 18: 1138-40.
34. Shohet RV, Garcia JA, Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia. J Mol Med 2007; 85: 1309-15.
35. Zolk O, Solbach TF, Eschenhagen T, Weidemann A, Fromm MF. Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failure. Biochem Biophys Res Commun 2008; 376: 315-20.
36. Heinl-Green A, Radke PW, Munkonge FM, et al. The efficacy of a 'master switch gene' in a porcine model of chronic myocardial ischaemia. Eur Heart J 2005; 26: 1327-32.
37. Kilian EG, Sadoni S, Vicol C, et al. Myocardial transfection of hypoxia inducible factor-1 alpha via an adenoviral vector during coronary artery bypass grafting-a multicenter phase I and safety study. Circ J 2010; 74: 916-24.
38. Ruel M, Wu GF, Khan TA, et al. Inhibition of the cardiac angiogenic response to surgical FGF-2 therapy in a swine endothelial dysfunction model. Circulation 2003; 108: 335-40.
39. Petersen B, Lucas-Hahn A, Oropeza M, et al. Development and validation of a highly efficient protocol of porcine somatic cloning using preovulatory embryo transfer in peripubertal gilts. Cloning Stem Cells 2008; 10: 355-62.
40. Renner S, Fehlings C, Herbach N, et al. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 2010; 59: 1228-38.